Invuity Reports 2016 Second Quarter and Six-Month Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Invuity Reports 2016 Second Quarter and Six-Month Financial Results

SAN FRANCISCO, July 19, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading surgical photonics company, today reported financial results for the second quarter and six months ended June 30, 2016.

Q2 2016 Highlights

  • Revenue grew 73 percent to $8.2 million compared to revenue of $4.7 million in the 2015 second quarter.
  • Gross margin expansion continued to 74.6 percent compared to 61.0 percent for the 2015 second quarter.
  • Approximately 610 customers purchased Invuity devices in the second quarter of 2016, up from 445 customers in the second quarter of 2015.
  • Approximately 186,000 procedures have been performed using Invuity devices.

"We had a strong second quarter highlighted by 73 percent revenue growth and continued execution on our development plans to expand our advanced photonics technology to additional complementary surgical procedures and modalities,” said President and CEO Philip Sawyer.  “We are pleased with our progress to date and excited about our momentum towards the widespread adoption of our unique devices and technologies, which provide meaningful clinical and economic value to surgeons and hospitals.”

Financial Results

Revenue was $8.2 million for the second quarter 2016, compared to $4.7 million for the second quarter in 2015, driven by an increase in active accounts and an increase in the revenue per active account.

Gross margin for the 2016 second quarter was 74.6 percent, compared to 61.0 percent for the same period in 2015. Gross margin has benefited from the recent introduction of our non-conductive polymer based retractors, and from overhead efficiencies due to increased sales volumes.

Total operating expenses for the 2016 second quarter were $15.8 million, compared to $11.8 million in the prior year period. We have continued to invest in our commercial platform consistent with our stated objectives, including the continued ramp up in sales reps and increased product development efforts in support of our new product pipeline.

The net loss for the second quarter of 2016 was $10.1 million, or $0.76 loss per share, compared to a net loss of $9.3 million, or $3.20 loss per share, for the second quarter of 2015.

The Company's balance sheet as of June 30, 2016 showed total cash and cash equivalents of $25.5 million.

Conference Call

Invuity's management will discuss the Company's financial results for the second quarter ended June 30, 2016, and provide a general business update during a conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time today, July 19, 2016. To join the live call, participants may dial 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 47469934.  To listen to the live call via Invuity's website, go to www.invuity.com , in the Events & Presentations section. A webcast replay of the call will be available following the conclusion of the call for a period of 90 days in the Events & Presentations section of the website.

About Invuity®

Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com .  

Forward-Looking Statements

This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding financial results, future product introductions, future marketing initiatives, market opportunities and potential results from future new initiatives. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the Securities and Exchange Commission, including, without limitation, under the captions: "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk Factors," which are on file with the Securities and Exchange Commission.

INVUITY, INC.
Condensed Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2016     2015     2016     2015  
Revenue   $ 8,223     $ 4,747     $ 14,627     $ 9,189  
Cost of goods sold     2,091       1,849       4,196       3,571  
Gross profit     6,132       2,898       10,431       5,618  
Operating expenses:                                
Research and development     2,340       1,857       4,941       3,757  
Selling, general and administrative     13,429       9,907       26,750       18,840  
Total operating expenses     15,769       11,764       31,691       22,597  
Loss from operations     (9,637 )     (8,866 )     (21,260 )     (16,979 )
Interest expense     (505 )     (504 )     (1,009 )     (873 )
Interest and other income (expense), net     13       24       30       (526 )
Net loss and comprehensive loss   $ (10,129 )   $ (9,346 )   $ (22,239 )   $ (18,378 )
Net loss per common share, basic and diluted   $ (0.76 )   $ (3.20 )   $ (1.66 )   $ (10.11 )
Weighted-average shares used to compute net loss per common share, basic and diluted     13,404,007       2,919,823       13,399,775       1,817,673  
                                 
Balance Sheet
as of June 30, 2016 and December 31, 2015
(In thousands, except share and per share amounts)
(Unaudited)
 
    June 30, 2016     December 31, 2015  
                 
Assets                
Current assets:                
Cash and cash equivalents   $ 25,456     $ 46,296  
Accounts receivable, net     4,514       3,619  
Inventory     5,450       5,182  
Prepaid expenses and other current assets     572       923  
Total current assets     35,992       56,020  
Restricted Cash     1,090       1,090  
Property and equipment, net     8,752       9,195  
Other non-current assets     285       -  
Total assets   $ 46,119     $ 66,305  
Liabilities, Preferred Stock and Stockholders’ Equity                
Current liabilities:                
Accounts payable   $ 2,369     $ 2,458  
Accrued and other current liabilities     4,951       4,214  
Short-term debt—related party     750       —  
Total current liabilities     8,070       6,672  
Deferred rent     2,771       2,810  
Long-term debt—related party     13,801       14,480  
Total liabilities     24,642       23,962  
Commitments and contingencies                
Stockholders’ equity :                
Preferred stock, $0.001 par value—10,000,000 shares authorized at June 30, 2016 and December 31, 2015, respectively; no shares issued and outstanding at June 30, 2016 and December 31, 2015     —       —  
Common stock, $0.001 par value—100,000,000 shares authorized at June 30, 2016 and December 31, 2015, respectively; 13,444,818 and 13,392,358 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively     13       13  
Additional paid-in capital     149,309       147,937  
Accumulated deficit     (127,845 )     (105,607 )
Total stockholders’ equity     21,477       42,343  
Total liabilities and stockholders’ equity   $ 46,119     $ 66,305  
                 

 

CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 irdept@invuity.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 253

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 112

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
UN Integrity Accelerator Targets Corporate Corruption

Updated Category News Views 10

Corruption rarely arrives wearing a villain costume; it shows up as a rushed payment, a friendly intermediary, or a contract nobody wants examined too closely. That is why the United Nations Global Compact's new Business Integrity Accelerator deserves a sober look. Launched November 18, 2026, the programme is not a magic shield, and nobody should sell it as one. But it...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 138

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 71

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 81

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Visa Direct Tests Stablecoin Prefunding in Asia-Pacific

Updated Category News Views 103

Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $100 into a Remarkable Asset with ISRG

Updated Category News Views 310

Investing in Intuitive Surgical: A Decade of Growth Investing in stocks can often lead to impressive returns, and when it comes to Intuitive Surgical (NASDAQ: ISRG), this statement holds particularly true over the past decade. With a remarkable annualized return of 24.63%, Intuitive Surgical has substantially outperformed the market, making it an attractive consideration...

Continue Reading
Giftify, Inc. Empowers Consumers Amid Increasing Food Costs

Updated Category News Views 181

How Giftify, Inc. is Supporting Consumers with Savings In a time where food prices are skyrocketing, especially in the grocery sector, Giftify, Inc. (NASDAQ: GIFT), the company behind the CardCash.com platform, is stepping up to support consumers. With rising egg prices and the increasing impact of inflation, Giftify is providing a practical solution for everyday...

Continue Reading
HCA Healthcare Posts Strong Results, Showcases Growth Potential

Updated Category News Views 315

HCA Healthcare Inc. Surpasses Expectations with Q3 Results HCA Healthcare Inc. (NYSE: HCA), recognized as one of the largest hospital operators in the country, recently shared its financial results for the third quarter of 2025. The company reported a notable increase in its financial metrics, showcasing resilience and growth amidst the evolving healthcare landscape....

Continue Reading
MedEx Ambulance Addresses Security Incident Resolution Steps

Updated Category News Views 379

Understanding the Recent Data Security Incident MedEx Ambulance, known for its dedication to emergency services, has recently faced a troubling data security incident. This incident has raised concerns about unauthorized access to both patient health records and employee personal details. Although operations have continued without disruption, MedEx feels it's crucial to...

Continue Reading
Blue Apron Tops Rankings for Home Meal Delivery Services

Updated Category News Views 139

Blue Apron Achieves Top Rank for Home Meal Delivery Blue Apron has risen to the highest rank for home-cooked meals through an extensive evaluation by Expert Consumers. This independent assessment focused on various meal delivery services, gauging them based on ingredient quality, recipe clarity, sourcing transparency, ease of use, and overall support for home cooking. Why...

Continue Reading